Am J Physiol Cell Physiol Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Cell Physiol 296: C1329-C1337, 2009. First published March 11, 2009; doi:10.1152/ajpcell.00513.2008
0363-6143/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Figures and Tables
Right arrow All Versions of this Article:
296/6/C1329    most recent
00513.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Mattaliano, M. D.
Right arrow Articles by Shih, H. H.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mattaliano, M. D.
Right arrow Articles by Shih, H. H.

VASCULAR BIOLOGY

LOX-1-dependent transcriptional regulation in response to oxidized LDL treatment of human aortic endothelial cells

Mark D. Mattaliano,1 Christine Huard,1 Wei Cao,1 Andrew A. Hill,1 Wenyan Zhong,1 Robert V. Martinez,1 Doug C. Harnish,2 Janet E. Paulsen,1 and Heather H. Shih1

1Biological Technologies, Wyeth Research, Cambridge, Massachusetts; and 2Department of Cardiovascular and Metabolic Diseases, Wyeth Research, Collegeville, Pennsylvania

Submitted 7 October 2008 ; accepted in final form 5 March 2009

Oxidized low-density lipoprotein (OxLDL) has been implicated as a proatherogenic factor with a pathological role in the induction of endothelial dysfunction. Endothelial cells bind and uptake OxLDL primarily through the scavenger receptor lectin-like oxidized-low-density lipoprotein receptor-1 (LOX-1), which is believed to mediate critical effects of OxLDL in endothelial cells. To examine the biological events following LOX-1 activation by OxLDL, we used cDNA microarray analysis to globally analyze gene expression changes induced by OxLDL treatment of human aortic endothelial cell line (HAECT) cells overexpressing LOX-1. Consistent with reported functions of OxLDL, in control HAECT cells, OxLDL elicited gene changes in the oxidative stress pathway and other signaling pathways related to OxLDL. With OxLDL treatment, LOX-1-dependent gene expression changes associated with inflammation, cell adhesion, and signal transduction were observed. The transcripts of a number of cytokines and chemokines were induced, which included interleukin-8, CXCL2, CXCL3, and colony-stimulating factor-3. The secretion of these cytokines was confirmed by enzyme-linked immunosorbent assay analysis. In addition, our data revealed a novel link between LOX-1 and a number of genes, including Delta/notch-like epidermal growth factor repeat containing, stanniocalcin-1, cAMP response element modulator, and dual specificity phosphatase 1. Promoter analysis on the genes that changed as a result of LOX-1 activation by OxLDL allowed us to identify early growth response 1 and cAMP response element-binding protein as potential novel transcription factors that function downstream of LOX-1. Our study has enabled us to elucidate the gene expression changes following OxLDL activation of LOX-1 in endothelial cells and discover novel downstream targets for LOX-1.

oxidized low-density lipoprotein; microarray; gene transcription



Address for reprint requests and other correspondence: H. H. Shih, Biological Technologies, Wyeth Research, 87 CambridgePark Drive, Cambridge, MA 02140 (e-mail: hshih{at}wyeth.com)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.